Related Experiment Video

Updated: Mar 2, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.2K

MELD Exceptions for Hepatocellular Carcinoma: Regional Variations in the Impact of the Share 35 Liver Allocation

Elaine Y Cheng1,2

  • 1Division of Liver and Pancreas Transplantation, Department of Surgery, University of California Los Angeles, Los Angeles, CA.

Clinical Transplants
|May 18, 2017
PubMed

Insights

Liver allocation policies historically favored exception scores, but recent changes show uneven regional impacts. This highlights geographic inequities in transplant access, particularly for liver cancer patients, needing strategies for fair organ distribution.

Area of Science:

  • Organ transplantation
  • Public health policy
  • Health equity

Background:

  • The Organ Procurement and Transplantation Network (OPTN) liver allocation policies have historically prioritized candidates with Model for End-Stage Liver Disease (MELD) exception scores.
  • The use of MELD exceptions has steadily increased since the MELD policy's introduction.
  • Recent policy adjustments, such as Share 35, aimed to decrease this preference.

Purpose of the Study:

  • To analyze the impact of recent OPTN liver allocation policy changes on MELD exception candidates.
  • To investigate geographic inequities and regional variations in liver transplant practices.
  • To focus on liver transplant candidates with hepatocellular carcinoma (HCC) exceptions and assess organ distribution fairness.

Main Methods:

  • Analysis of OPTN liver allocation policies and historical data.
  • Examination of the effects of Share 35 and subsequent policy modifications.
  • Comparative study of regional variations in transplant practices and exception score utilization.

Main Results:

  • Recent policy changes have partially reduced the preference for MELD exception candidates.
  • The impact of these policy changes on candidate prioritization varies significantly across different geographic regions.
  • Regional disparities in liver transplant practices persist, affecting equitable organ distribution.

Conclusions:

  • Despite policy reforms, geographic inequities in liver allocation remain a significant concern.
  • Regional variations in transplant practices necessitate targeted strategies to ensure fair organ distribution.
  • Addressing these disparities is crucial for improving access to liver transplantation for all eligible patients, including those with HCC exceptions.
Keywords:
MELD exception scoresOPTNShare 35liverliver allocationregistrytransplantation

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.8K

Related Concept Videos

Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
678
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
316
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
302
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K